Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:mammary tumor incidence/prevalence measurement
go back to main search page
Accession:CMO:0000946 term browser browse the term
Definition:A measurement in which the number of individuals in a study population displaying one or more tumors of the mammary gland at a point in time or developing such growths within a determined period of time, are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A tumor is an abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.


show annotations for term's descendants           Sort by:
 
mammary tumor incidence/prevalence measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mcs31 Mammary carcinoma susceptibility QTL 31 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 9:77,813,894...111,552,878 JBrowse link
Q Mcs32 Mammary carcinoma susceptibility QTL 32 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 1:115,540,693...238,914,717 JBrowse link
Q Mcs33 Mammary carcinoma susceptibility QTL 33 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 5:131,345,754...166,875,058 JBrowse link
Q Mcs34 Mammary carcinoma susceptibility QTL 34 IDA RGD PMID:23967281 RGD:7794780
percentage of study population developing mammary tumors during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca4 Estrogen-induced mammary cancer QTL 4 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 7:62,004,452...101,773,158 JBrowse link
Q Emca5 Estrogen-induced mammary cancer QTL 5 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 3:43,827,364...169,034,231 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    tumor measurement 88
      mammary tumor measurement 50
        mammary tumor incidence/prevalence measurement 6
          percentage of study population developing mammary tumors during a period of time 2
          percentage of study population displaying mammary tumors at a point in time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          organ tumorous lesion incidence/prevalence measurement 18
            tumor incidence/prevalence measurement 16
              mammary tumor incidence/prevalence measurement 6
                percentage of study population developing mammary tumors during a period of time 2
                percentage of study population displaying mammary tumors at a point in time 0
paths to the root